Impact of Implantable Cardioverter-Defibrillator Interventions on All-Cause Mortality in Heart Failure Patients
Authors:
- 1 May 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 27 (3) , 160-166
Abstract
Implantable cardioverter-defibrillators (ICDs) have a unique role in the primary and secondary prevention of sudden cardiac death. However, appropriate and inappropriate ICD interventions [antitachycardia pacing (ATP) or shocks] can result in deleterious effects. The aim of our study was to systematically review the existing data about the impact of ICD interventions on all-cause mortality in heart failure patients with reduced ejection fraction (HFrEF). We systematically searched MEDLINE (by using PubMed Web-based search engine) without any limits until September 30, 2017. After screening 17,752 records, a total of 17 studies met our inclusion criteria and were included in our meta-analysis. Our data showed that in patients with HFrEF, appropriate [hazard ratio (HR), 2.00; 95% confidence interval (CI), 1.52–2.63; P < 0.01; I 2 88%] and inappropriate [HR, 1.30; 95% CI, 1.07–1.58; P < 0.01; I 2 26%] ICD interventions were significantly associated with increased all-cause mortality. However, neither appropriate ATP [HR, 1.27; 95% CI, 0.80–2.02; P = 0.30; I 2 62%] nor inappropriate ATP [HR, 1.01; 95% CI, 0.49–2.07; P = 0.98; I 2 46%] were significantly associated with all-cause mortality in this patient population. In conclusion, ICD shocks are associated with a worse prognosis in HFrEF.Keywords
This publication has 42 references indexed in Scilit:
- Myocardial Injury Secondary to ICD Shocks: Insights from Patients with Lead FracturePacing and Clinical Electrophysiology, 2013
- Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillatorInternational Journal of Cardiology, 2013
- Impact of Shocks on Mortality in Patients with Ischemic or Dilated Cardiomyopathy and Defibrillators Implanted for Primary PreventionPLOS ONE, 2013
- Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 YearsThe American Journal of Cardiology, 2012
- Inappropriate Implantable Cardioverter-Defibrillator ShocksJACC, 2011
- Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic CardiomyopathyPacing and Clinical Electrophysiology, 2010
- Troponin T elevation after implanted defibrillator discharge predicts survivalHeart, 2009
- Prognostic Importance of Defibrillator Shocks in Patients with Heart FailureNew England Journal of Medicine, 2008
- Predictors of Driving Ability Following Stroke: A Systematic ReviewTopics in Stroke Rehabilitation, 2007
- Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillatorsHeart Rhythm, 2006